Repositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids

Coronavirus‐related disease 2019 (COVID‐19) became a pandemic in February 2020, and worldwide researchers try to tackle the disease with approved drugs of all kinds, or to develop novel compounds inhibiting viral spreading. Flavonoids, already investigated as antivirals in general, also might bear a...

Descripción completa

Detalles Bibliográficos
Autores principales: Goris, Tobias, Pérez‐Valero, Álvaro, Martínez, Igor, Yi, Dong, Fernández‐Calleja, Luis, San León, David, Bornscheuer, Uwe T., Magadán‐Corpas, Patricia, Lombó, Felipe, Nogales, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675739/
https://www.ncbi.nlm.nih.gov/pubmed/33047877
http://dx.doi.org/10.1111/1751-7915.13675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675739/
https://www.ncbi.nlm.nih.gov/pubmed/33047877
http://dx.doi.org/10.1111/1751-7915.13675

Ejemplares similares